Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04193085 · ClinicalTrials.gov registry record
Wearable Technology to Assess Gait Function in SMA and DMD
A clinical trial of Duchenne Muscular Dystrophy and Spinal Muscular Atrophy Type 3, sponsored by Columbia University.
- Completed
- Registry status
- 39
- Enrollment target
- 1
- Study location
NCT04193085 is a study of Duchenne Muscular Dystrophy and Spinal Muscular Atrophy Type 3 that has completed, run by Columbia University. The registered enrollment target is 39 participants, below the 412-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04193085, a study of Duchenne Muscular Dystrophy and Spinal Muscular Atrophy Type 3, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to devise instrumented insoles capable of accurately measuring gait at each footfall, over multiple hours in any environment. To achieve high accuracy, the investigators will develop a new learning-based calibration framework. Features will be tested in controlled lab settings 39 during a single visit in people with SMA (13), DMD (13) and healthy controls (13) and in 15 participants in real-life environments.
Conditions Studied
Interventions
- OTHER Observational
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2019-11-25 |
| Est. Completion | 2023-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04193085
The ClinicalTrials.gov registry entry for NCT04193085 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 412-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (91% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Duchenne Muscular Dystrophy appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT04193085 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04193085 about?
NCT04193085 is a clinical study titled "Wearable Technology to Assess Gait Function in SMA and DMD". The purpose of this project is to devise instrumented insoles capable of accurately measuring gait at each footfall, over multiple hours in any environment. To achieve high accuracy, the investigators will develop a new learning-based calibration framework. Features will be tested in controlled lab ...
What is the current status of trial NCT04193085?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2019-11-25. Estimated completion is 2023-08-31.
What conditions does trial NCT04193085 study?
This clinical trial studies the following conditions: Duchenne Muscular Dystrophy, Spinal Muscular Atrophy Type 3.
What interventions are being tested in trial NCT04193085?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT04193085?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04193085 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Duchenne Muscular Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
RECRUITING · Phase 1
-
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
RECRUITING · Phase 2
-
Once Weekly Infant Corticosteroid Trial for DMD
RECRUITING · Phase 4
-
The Duchenne Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.